Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)

BACKGROUND: Erythrodermic and generalized pustular psoriasis are rare, difficult to treat forms of psoriasis. In previous reports, we documented 24‐ and 52‐week findings of an open‐label, phase 3 trial (UNCOVER‐J) of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Eur Acad Dermatol Venereol
Hauptverfasser: Okubo, Y., Mabuchi, T., Iwatsuki, K., Elmaraghy, H., Torisu‐Itakura, H., Morisaki, Y., Nakajo, K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2018
Schlagworte:
Psoriasis
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587497/
https://ncbi.nlm.nih.gov/pubmed/30317671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15287
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge